Effects of ralfinamide, a Na+ channel blocker, on firing properties of nociceptive dorsal root ganglion neurons of adult rats.
Recent studies revealed that ralfinamide, a Na(+) channel blocker, suppressed tetrodotoxin-resistant Na(+) currents in dorsal root ganglion (DRG) neurons and reduced pain reactions in animal models of inflammatory and neuropathic pain. Here, we investigated the effects of ralfinamide on Na(+) currents; firing properties and action potential (AP) parameters in capsaicin-responsive and -unresponsive DRG neurons from adult rats in the presence of TTX (0.5 microM). Ralfinamide inhibited TTX-resistant Na(+) currents in a frequency- and voltage-dependent manner. Small to medium sized neurons exhibited different firing properties during prolonged depolarizing current pulses (600 ms). One group of neurons fired multiple spikes (tonic), while another group fired four or less APs (phasic). In capsaicin-responsive tonic firing neurons, ralfinamide (25 microM) reduced the number of APs from 10.6+/-1.8 to 2.6+/-0.7 APs/600 ms, whereas in capsaicin-unresponsive tonic neurons, the drug did not significantly change firing (8.4+/-0.9 in control to 6.6+/-2.0 APs/600 ms). In capsaicin-responsive phasic neurons, substance P and 4-aminopyridine induced multiple spikes, an effect that was reversed by ralfinamide (25 microM). In addition to effects on firing, ralfinamide increased the threshold, decreased the overshoot, and increased the rate of rise of the AP. To conclude, ralfinamide suppressed afferent hyperexcitability selectively in capsaicin-responsive, presumably nociceptive neurons, but had no measurable effects on firing in CAPS-unresponsive neurons. The action of ralfinamide to selectively inhibit tonic firing in nociceptive neurons very likely contributes to the effectiveness of the drug in reducing inflammatory and neuropathic pain as well as bladder overactivity.
Yamane
Hana
H
Department of Pharmacology, University of Pittsburgh School of Medicine, E1304 Biomedical Science Tower, Pittsburgh, PA 15261, USA.
de Groat
William C
WC
Sculptoreanu
Adrian
A
D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D004351:Drug Resistance; D004558:Electric Stimulation; D004594:Electrophysiology; D005464:Fluorobenzenes / Q000494:pharmacology*; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018689:Sensory System Agents / Q000494:pharmacology; D026941:Sodium Channel Blockers / Q000494:pharmacology*; D013373:Substance P / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D005464:Fluorobenzenes; D018689:Sensory System Agents; D026941:Sodium Channel Blockers; C499681:Ralfinamide; D013373:Substance P; D013779:Tetrodotoxin; D015761:4-Aminopyridine; D002211:Capsaicin
Scand J Urol Nephrol Suppl. 1999;201:73-5
10573780
Exp Neurol. 2000 Jan;161(1):273-84
10683293
Pain. 2000 Dec 15;89(1):47-52
11113292
Anesthesiology. 2001 Jan;94(1):137-44
11135733
J Neurophysiol. 2001 Aug;86(2):629-40
11495938
J Neurosci. 2001 Nov 1;21(21):8690-6
11606657
Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G1045-51
12016130
Brain Res. 2003 Feb 14;963(1-2):132-8
12560118
Pain. 2003 Mar;102(1-2):17-25
12620593
Mol Cells. 2003 Oct 31;16(2):256-9
14651270
Annu Rev Pharmacol Toxicol. 2004;44:371-97
14744251
Neuroscience. 2004;123(4):867-74
14751280
Br J Pharmacol. 2004 Jun;142(3):576-84
15148257
J Pharmacol Exp Ther. 2004 Jul;310(1):159-68
15010502
J Gen Physiol. 1977 Apr;69(4):497-515
300786
Biochim Biophys Acta. 1977 Nov 14;472(3-4):373-98
334262
Eur J Pharmacol. 1989 Aug 29;167(3):419-22
2553444
J Auton Nerv Syst. 1992 May 15;38(3):201-8
1613209
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9270-5
8799190
J Physiol. 1996 Jul 1;494 ( Pt 1):1-16
8814602
Neuroscience. 1998 Mar;83(2):633-43
9460769
J Neurophysiol. 1998 Apr;79(4):1746-54
9535944
J Neurosci. 1999 Jun 1;19(11):4644-53
10341262
Toxicon. 2005 Mar 15;45(4):431-42
15733564
Eur J Pharmacol. 2005 Mar 14;510(3):197-208
15763243
J Physiol. 2005 Apr 15;564(Pt 2):437-50
15705651
Exp Neurol. 2005 Jun;193(2):437-43
15869946
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9382-7
15964986
J Pain. 2006 Jan;7(1 Suppl 1):S31-7
16426999
J Pain. 2006 May;7(5 Suppl 3):S1-29
16632328
J Physiol. 2006 Oct 1;576(Pt 1):257-67
16857712
J Neurosci. 2006 Oct 18;26(42):10847-55
17050722
J Neurophysiol. 2007 Feb;97(2):1258-65
17108087
Exp Neurol. 2007 May;205(1):92-100
17362934